We are live on ! Find out more
T

TOBAM Portfolio holdings

AUM $412M
1-Year Est. Return 18.33%
This Fund
S&P 500
This Quarter Est. Return
+1.57%
1 Year Est. Return
+18.33%
3 Year Est. Return
+56.05%
5 Year Est. Return
+49%
10 Year Est. Return
+255.15%
AUM
$638M
AUM Growth
-$478M
Cap. Flow
-$481M
Cap. Flow %
-75.43%
Top 10 Hldgs %
26.77%
Holding
396
New
19
Increased
55
Reduced
247
Closed
70

Top Buys

Rank Stock Value
1
JBL icon
Jabil
JBL
+$6.21M
2
DKS icon
Dick's Sporting Goods
DKS
+$5.56M
3
GL icon
Globe Life
GL
+$4.73M
4
AKAM icon
Akamai
AKAM
+$4.28M
5
EXPE icon
Expedia Group
EXPE
+$2.86M

Top Sells

Rank Stock Value
1
PGR icon
Progressive
PGR
+$22M
2
LLY icon
Eli Lilly
LLY
+$17.1M
3
NEM icon
Newmont
NEM
+$16.8M
4
MCK icon
McKesson
MCK
+$15.8M
5
CHD icon
Church & Dwight Co
CHD
+$14.5M

Sector Composition

Rank Sector Weight
1 Healthcare 30.76%
2 Consumer Staples 20.45%
3 Technology 14.41%
4 Financials 10.29%
5 Communication Services 9.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LLY icon
1
Eli Lilly
LLY
$1.03T
$20.1M 3.15%
22,172
-21,432
-49% -$17.1M
T icon
2
AT&T
T
$179B
$19.1M 2.99%
999,054
-654,269
-40% -$11.4M
UTHR icon
3
United Therapeutics
UTHR
$21B
$17.9M 2.81%
56,258
-52,389
-48% -$13.9M
HUM icon
4
Humana
HUM
$48.8B
$16.9M 2.65%
45,165
-39,777
-47% -$13.4M
MCK icon
5
McKesson
MCK
$107B
$16.7M 2.62%
28,654
-28,409
-50% -$15.8M
CHD icon
6
Church & Dwight Co
CHD
$23.4B
$16.5M 2.59%
159,219
-137,198
-46% -$14.5M
GIS icon
7
General Mills
GIS
$21B
$16.5M 2.58%
260,431
-210,294
-45% -$14.4M
CBOE icon
8
Cboe Global Markets
CBOE
$31.2B
$16.3M 2.55%
95,805
-65,317
-41% -$11.6M
ABBV icon
9
AbbVie
ABBV
$460B
$15.9M 2.49%
92,627
-82,734
-47% -$13.7M
CLX icon
10
Clorox
CLX
$11.4B
$14.9M 2.33%
109,087
-85,453
-44% -$11.9M
PFE icon
11
Pfizer
PFE
$164B
$14.3M 2.24%
511,355
-396,687
-44% -$10.9M
MRK icon
12
Merck
MRK
$376B
$13.6M 2.13%
109,482
-98,864
-47% -$12.7M
K
13
DELISTED
Kellanova
K
$13.1M 2.05%
226,763
-210,719
-48% -$12.4M
VZ icon
14
Verizon
VZ
$210B
$13M 2.03%
314,527
-231,346
-42% -$9.32M
NEM icon
15
Newmont
NEM
$137B
$13M 2.03%
309,707
-412,087
-57% -$16.8M
SJM icon
16
J.M. Smucker
SJM
$13.7B
$12.5M 1.95%
114,244
-109,756
-49% -$12.4M
NBIX icon
17
Neurocrine Biosciences
NBIX
$16.1B
$12.5M 1.95%
90,465
-87,788
-49% -$12M
ANET icon
18
Arista Networks
ANET
$241B
$12.3M 1.92%
139,852
-146,804
-51% -$10.9M
KR icon
19
Kroger
KR
$35.8B
$11.6M 1.82%
232,877
-247,688
-52% -$13.3M
JNJ icon
20
Johnson & Johnson
JNJ
$671B
$11.5M 1.8%
78,454
-73,639
-48% -$11M
CPB icon
21
Campbell Soup
CPB
$6.6B
$11.4M 1.78%
251,621
-202,681
-45% -$9.03M
HRL icon
22
Hormel Foods
HRL
$11.9B
$9.89M 1.55%
324,513
-72,341
-18% -$2.43M
BMY icon
23
Bristol-Myers Squibb
BMY
$139B
$9.07M 1.42%
218,309
-143,411
-40% -$6.42M
PGR icon
24
Progressive
PGR
$130B
$8.38M 1.31%
40,359
-104,889
-72% -$22M
MKTX icon
25
MarketAxess Holdings
MKTX
$5.75B
$8.31M 1.3%
41,438
-28,433
-41% -$5.86M
1
2 3 4 5

Similar funds

EC
EntryPoint Capital New York $412M AUM 28.52% 1-Year Est. Return
WIP
WealthCare Investment Partners Portsmouth, Rhode Island $412M AUM 24.95% 1-Year Est. Return
KP
Kiltearn Partners Edinburgh, United Kingdom $412M AUM 26.77% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $412M AUM 34.27% 1-Year Est. Return
AWP
Accretive Wealth Partners Parsippany, New Jersey $412M AUM 15.82% 1-Year Est. Return
THCM
Taylor Hoffman Capital Management Richmond, Virginia $412M AUM 57.16% 1-Year Est. Return
PA
Prism Advisors Studio City, California $412M AUM 20.58% 1-Year Est. Return
HP
Hilltop Partners Mishawaka, Indiana $412M AUM 26.77% 1-Year Est. Return

TOBAM's Q2 2024 Portfolio in Review

As of Q2 2024, TOBAM held 396 positions worth $638M, down 43% from $1.12B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

TOBAM withdrew a net $481M in Q2 2024, closing 70 positions and reducing 247 holdings. Its most notable exit was Markel Group, an estimated $1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 33% a quarter earlier, followed by Consumer Staples and Technology.

Against the trend, TOBAM opened a new position in Globe Life worth $4.7M.

  • TOBAM's largest Q2 2024 buy was Globe Life: 57,069 shares worth $4.7M.
  • TOBAM added most to Jabil in Q2 2024, an estimated $6.21M increase.
  • TOBAM's biggest Q2 2024 reduction was Progressive, cutting an estimated $22M.
  • TOBAM fully exited Markel Group in Q2 2024, selling an estimated $1M.
  • TOBAM's ten largest holdings make up 27% of its $638M portfolio in Q2 2024.
  • TOBAM opened 19 new positions and closed 70 in Q2 2024.
  • TOBAM's portfolio value fell 43% quarter-over-quarter to $638M.

Based on TOBAM's 13F filing for Q2 2024, filed 29 Jul 2024.